Page 1045 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

26. Ventilation with lower tidal volumes as compared with tra- pneumonia in adults. Infectious Diseases Society of America.
ditional tidal volumes for acute lung injury and the acute Clin Infect Dis. 2000;31(2):347-382.
respiratory distress syndrome. The Acute Respiratory Distress 43. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify
Syndrome Network. N Engl J Med. 2000;342(18):1301-1308. low-risk patients with community-acquired pneumonia. N Engl
27. Bernard GR, Wheeler AP, Russell JA, et al. The effects of J Med. 1997;336(4):243-250.
ibuprofen on the physiology and survival of patients with 44. Rello J, Rodriguez R, Jubert P, Alvarez B. Severe community-
sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med. acquired pneumonia in the elderly: epidemiology and prognosis.
1997;336(13):912-918. Study Group for Severe Community-Acquired Pneumonia. Clin
28. Laterre PF, Garber G, Levy H, et al. Severe community-acquired Infect Dis. 1996;23(4):723-728.
pneumonia as a cause of severe sepsis: data from the PROWESS 45. Rello J, Rodriguez A, Torres A, et al. Implications of COPD
study. Crit Care Med. 2005;33(5):952-961. in patients admitted to the intensive care unit by community-
29. Laterre PF, Opal SM, Abraham E, et al. A clinical evaluation acquired pneumonia. Eur Respir J. 2006;27(6):1210-1216.
committee assessment of recombinant human tissue factor path- 46. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is
way inhibitor (tifacogin) in patients with severe community- associated with increased mortality in patients with community-
acquired pneumonia. Crit Care. 2009;13(2):R36. acquired pneumonia. Eur Respir J. 2006;28(2):346-351.
30. Mortensen EM, Kapoor WN, Chang CC, Fine MJ. Assessment of 47. Rello J, Quintana E, Ausina V, Net A, Prats G. A three-year
mortality after long-term follow-up of patients with community- study of severe community-acquired pneumonia with emphasis
acquired pneumonia. Clin Infect Dis. 2003;37(12):1617-1624. on outcome. Chest. 1993;103(1):232-235.
31. Yende S, D’Angelo G, Kellum JA, et al. Inflammatory markers at 48. Ruiz M, Ewig S, Torres A, et al. Severe community-acquired
hospital discharge predict subsequent mortality after pneumonia pneumonia: risk factors and follow-up epidemiology. Am
and sepsis. Am J Respir Crit Care Med. 2008;177(11):1242-1247. J Respir Crit Care Med. 1999;160(3):923-929.
32. Waterer GW, Kessler LA, Wunderink RG. Medium-term 49. von Baum H, Welte T, Marre R, Suttorp N, Ewig S. Community-
survival after hospitalization with community-acquired pneu- acquired pneumonia through Enterobacteriaceae and Pseudo-
monia. Am J Respir Crit Care Med. 2004;169(8):910-914. monas aeruginosa: diagnosis, incidence and predictors. Eur
33. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Respir J. 2010;35(3):598-605.
Survey: 2000 annual summary with detailed diagnosis and 50. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analy-
procedure data. Vital Health Stat. 2002;13(153):1-194. sis improves pathogen identification and epidemiologic study
34. Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, of pediatric parapneumonic empyema. Pediatr Infect Dis J.
Siu AL. Instability on hospital discharge and the risk of 2011;30(4):289-294.
adverse outcomes in patients with pneumonia. Arch Intern Med. 51. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies
2002;162(11):1278-1284. RJ. The bacteriology of pleural infection by genetic and stan-
35. Leroy O, Santre C, Beuscart C, et al. A five-year study of severe dard methods and its mortality significance. Am J Respir Crit
community-acquired pneumonia with emphasis on prognosis Care Med. 2006;174(7):817-823.
in patients admitted to an intensive care unit. Intens Care Med. 52. de Roux A, Marcos MA, Garcia E, et al. Viral community-
1995;21(1):24-31. acquired pneumonia in nonimmunocompromised adults.
36. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P. Severe Chest. 2004;125(4):1343-1351.
community-acquired pneumonia. Etiology, epidemiology, 53. Waterer GW, Kessler LA, Wunderink RG. Delayed administration
and prognosis factors. French Study Group for Community- of antibiotics and atypical presentation in community-acquired
Acquired Pneumonia in the Intensive Care Unit. Chest. 1994; pneumonia. Chest. 2006;130(1):11-15.
105(5):1487-1495.
54. Capp R, Chang Y, Brown DF. Accuracy of microscopic urine
37. Rello J, Catalan M, Diaz E, Bodi M, Alvarez B. Associations analysis and chest radiography in patients with severe sepsis and
between empirical antimicrobial therapy at the hospital and septic shock. J Emerg Med. 2012;42(1):52-57.
mortality in patients with severe community-acquired pneumonia.
Intens Care Med. 2002;28(8):1030-1035. 55. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious
Diseases Society of America/American Thoracic Society con-
38. Torres A, Serra-Batlles J, Ferrer A, et al. Severe community- sensus guidelines on the management of community-acquired
acquired pneumonia: epidemiology and prognostic factors. Am pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
Rev Respir Dis. 1991;144(2):312-318.
56. van der Eerden MM, Vlaspolder F, de Graaff CS, et al.
39. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of Comparison between pathogen directed antibiotic treatment
patients with community-acquired pneumonia: a meta-analysis. and empirical broad spectrum antibiotic treatment in patients
JAMA. 1996;275(2):134-141. with community acquired pneumonia: a prospective ran-
40. Angus DC, Marrie TJ, Obrosky DS, et al. Severe community- domised study. Thorax. 2005;60(8):672-678.
acquired pneumonia: use of intensive care services and evalu- 57. Waterer GW, Jennings SG, Wunderink RG. The impact of blood
ation of American and British Thoracic Society Diagnostic cultures on antibiotic therapy in pneumococcal pneumonia.
criteria. Am J Respir Crit Care Med. 2002;166(5):717-723. Chest. 1999;116(5):1278-1281.
41. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the manage- 58. van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T,
ment of adult lower respiratory tract infections. Eur Respir J. Jansen HM, Boersma WG. Value of intensive diagnostic micro-
2005;26(6):1138-1180. biological investigation in low- and high-risk patients with
42. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. community-acquired pneumonia. Eur J Clin Microbiol Infect
Practice guidelines for the management of community-acquired Dis. 2005;24(4):241-249.

Section05-O-ref.indd 2 1/20/2015 4:51:18 PM